CRF Health Approved to Use Electronic Version of SGRQ on TrialSlate Tablet Device

June 8, 2011 Naor Chazan

Plymouth Meeting, PA – June 8, 2011: CRF Health received approval to use an electronic version of the St. George Respiratory Questionnaire on its tablet PC based TrialSlate™ devices from instrument developer Professor Paul Jones of St. George’s University of London. The TrialSlate™ version can be considered equivalent to the paper version of the questionnaire according to the “Recommendations on Evidence Needed to Support Measurement Equivalence between Electronic and Paper-based Patient-Reported Outcome (PRO) Measures: ISPOR ePRO Good Research Practices Task Force Report” which provides guidelines for industry in response to the FDA PRO Guidance.

A study demonstrating the general usability and absence of any major issues with respondents completing the SGRQ on the tablet device was conducted by United BioSource Corporation (UBC) on CRF Health’s behalf and the results were summarized in a report.

The electronic version of the SGRQ provides clinical trial managers more flexibility in designing trials along with the many other benefits of using ePRO, including improved compliance, higher quality data, and more efficient clinical trials.

Mary Briggs, VP Global Sales & Marketing, commented, “Gaining these types of approvals from instrument authors and partnering with valued PRO thought leaders to expand the use of technology in clinical trials are two examples of CRF Health’s strategy to offer the best services in the global ePRO marketplace.”

#

About CRF Health

CRF Health is a global leader in ePRO (electronic patient reported outcomes) solutions for the life sciences industry. Through innovative technology, a thorough understanding of drug development, and mobile computing, CRF Health is driving the change to higher quality outcomes and more efficient paper-free clinical trials.

CRF Health’s ePRO technology has been used in more than 70 countries, on six continents and 68 regional languages, including several regional Indian dialects. CRF Health consistently demonstrates the industry’s highest patient compliance rates, while delivering unrivaled data accuracy and unmatched patient and site acceptance.

Since its founding in 2000, CRF Health continues to provide true global ePRO delivery and service. Headquartered in the US, CRF Health operates its R&D center of excellence in Helsinki, Finland and has offices around the world.

For more information, please visit www.crfhealth.com.

Media Contact
Heather Bilinski, Marketing Manager
CRF Health
4000 Chemical Road, Suite 400
Plymouth Meeting, PA 19462
Phone: +1 267.498.2349 | Fax: +1 215.565.0001
heather.bilinski@crfhealth.com

Enter content here

Previous
CRF Health partners with EuroQol to become a preferred eCOA provider granted permission to host its own web version of the EQ-5D™

Next
CRF Health To Present At Massachusetts Biotechnology Seminar